Physician
UPMC Somerset
UPMC Somerset was paid $2.89M by Medicaid between Jan 2018 and Dec 2024, across 189 billing codes. Its largest line is 99284, emergency room visit (serious) — 23% of everything it billed.
33Billing provider infoUPMC SOMERSET
SOMERSET, PA 15501
SOMERSET, PA 15501
33aNPI1912900168assigned 05/23/2005
33bProvider typeSurgery Physician
28Total paid$2.89M
24GClaims143,288
24DCodes billed189
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Surgery Physician providers in Pennsylvania
Rank by total paid#4 of 190
Median peer was paid$3K
This provider vs. median866×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 187 | $1K | |
| 2019 | 52 | $809.09 | |
| 2020 | 15,740 | $231K | |
| 2021 | 73,189 | $1.34M | |
| 2022 | 24,275 | $537K | |
| 2023 | 19,180 | $467K | |
| 2024incomplete | 10,665 | $315K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 23% | 10,178 | 9,700 | $666K |
| D2930 | Prefabricated stainless steel crown - primary tooth | 11% | 569 | 390 | $323K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 10.0% | 6,410 | 6,191 | $288K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 4.7% | 2,497 | 2,102 | $135K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 4.0% | 2,890 | 1,315 | $116K |
| 80053 | Comprehensive metabolic panel | 3.7% | 12,000 | 10,947 | $107K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 2.9% | 1,257 | 1,228 | $83K |
| 62323 | 2.8% | 360 | 344 | $81K | |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.5% | 506 | 488 | $73K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.3% | 2,883 | 2,728 | $65K |
| 11042 | Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm | 2.1% | 1,629 | 723 | $61K |
| 80050 | General health panel | 1.9% | 1,260 | 1,215 | $56K |
177 more codes
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.9% | 12,492 | $55K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.9% | 1,473 | $53K |
| 99285 | Emergency room visit (most serious) | 1.4% | 682 | $40K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 1.3% | 6,228 | $38K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.0% | 639 | $30K |
| 80061 | Lipid panel | <1% | 2,105 | $29K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 3,428 | $24K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 343 | $24K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,304 | $23K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 456 | $19K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 84 | $18K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 1,291 | $18K |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 1,319 | $17K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 234 | $17K |
| 84484 | <1% | 2,355 | $16K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 208 | $15K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 426 | $15K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 1,224 | $15K |
| 82553 | <1% | 2,202 | $14K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 936 | $14K |
| 84439 | <1% | 2,073 | $14K | |
| G0378 | Hospital observation service, per hour | <1% | 34 | $13K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 115 | $12K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 524 | $12K |
| 85730 | <1% | 2,221 | $11K | |
| 81001 | <1% | 4,261 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,531 | $9K |
| 83735 | <1% | 1,608 | $9K | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 154 | $9K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 250 | $8K |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 47 | $8K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,392 | $8K |
| 93971 | <1% | 135 | $8K | |
| 87040 | <1% | 739 | $8K | |
| 80320 | <1% | 669 | $7K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 7,476 | $7K |
| 85610 | <1% | 2,628 | $7K | |
| 83605 | <1% | 1,184 | $7K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 974 | $7K |
| 83690 | <1% | 1,523 | $6K | |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 42 | $6K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 29 | $5K |
| 82150 | <1% | 1,311 | $5K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 464 | $5K |
| 82805 | <1% | 182 | $5K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 13 | $5K |
| 83880 | <1% | 258 | $4K | |
| 82607 | <1% | 361 | $4K | |
| 87186 | <1% | 621 | $4K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 208 | $4K |
| 87077 | <1% | 676 | $4K | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 283 | $4K |
| D7140 | Extraction, erupted tooth or exposed root | <1% | 17 | $4K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 853 | $4K |
| 86003 | <1% | 13 | $3K | |
| 85027 | <1% | 580 | $3K | |
| 73564 | <1% | 180 | $3K | |
| 85379 | <1% | 387 | $3K | |
| 73610 | <1% | 185 | $3K | |
| 93017 | <1% | 98 | $3K | |
| 96376 | <1% | 288 | $3K | |
| 95886 | <1% | 74 | $3K | |
| 82728 | <1% | 231 | $3K | |
| 86618 | <1% | 93 | $2K | |
| 72110 | <1% | 107 | $2K | |
| 81003 | <1% | 823 | $2K | |
| 82043 | <1% | 272 | $2K | |
| 74018 | <1% | 176 | $2K | |
| 87081 | <1% | 398 | $2K | |
| 71250 | <1% | 39 | $2K | |
| 76377 | <1% | 275 | $2K | |
| 73030 | <1% | 139 | $2K | |
| 83540 | <1% | 209 | $2K | |
| 85652 | <1% | 638 | $2K | |
| 73630 | <1% | 192 | $2K | |
| 86803 | <1% | 98 | $2K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 160 | $2K |
| 36600 | <1% | 183 | $1K | |
| 84146 | <1% | 68 | $1K | |
| 80076 | <1% | 170 | $1K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 28 | $1K |
| 87070 | <1% | 285 | $1K | |
| 85007 | <1% | 416 | $1K | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 45 | $1K |
| 87340 | <1% | 92 | $1K | |
| 99214 | Doctor's office visit, returning patient (more involved) | <1% | 17 | $1K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 61 | $1K |
| 86038 | <1% | 78 | $1K | |
| 76536 | <1% | 24 | $1K | |
| 84481 | <1% | 46 | $1K | |
| G0399 | Home sleep test (hst) with type iii portable monitor, unattended; minimum of 4 channels: 2 respiratory movement/airflow, 1 ecg/heart rate and 1 oxygen saturation | <1% | 12 | $998.12 |
| 90715 | <1% | 78 | $982.92 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 168 | $943.58 |
| 82570 | <1% | 139 | $882.80 | |
| 87205 | <1% | 283 | $865.66 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 90 | $864.04 |
| 73502 | <1% | 55 | $863.14 | |
| 81025 | <1% | 379 | $846.08 | |
| 83615 | <1% | 129 | $837.60 | |
| 83550 | <1% | 170 | $834.68 | |
| 70486 | <1% | 12 | $771.14 | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 15 | $730.08 |
| 76830 | Ultrasound, transvaginal | <1% | 15 | $730.08 |
| 73130 | <1% | 66 | $708.38 | |
| 86140 | <1% | 268 | $700.20 | |
| 87339 | <1% | 108 | $689.67 | |
| 86308 | <1% | 100 | $680.70 | |
| 86255 | <1% | 14 | $608.47 | |
| 76770 | <1% | 13 | $591.08 | |
| 96367 | <1% | 23 | $579.23 | |
| 84100 | <1% | 93 | $565.17 | |
| 87807 | <1% | 46 | $560.74 | |
| 84550 | <1% | 93 | $551.47 | |
| 82746 | <1% | 46 | $512.40 | |
| 76642 | <1% | 15 | $410.63 | |
| 73110 | <1% | 43 | $407.64 | |
| 84703 | <1% | 41 | $394.58 | |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 14 | $394.20 |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 89 | $382.66 |
| 87806 | <1% | 13 | $378.85 | |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | <1% | 156 | $373.80 |
| 86706 | <1% | 28 | $365.80 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,771 | $349.99 |
| 86885 | <1% | 78 | $338.00 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,971 | $334.62 |
| 88175 | Cytopathology, cervical or vaginal, any reporting system; collected in preservative fluid, automated thin layer | <1% | 16 | $326.57 |
| 94010 | <1% | 46 | $321.00 | |
| 82248 | <1% | 64 | $313.80 | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 30 | $306.60 |
| 82565 | <1% | 55 | $273.24 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 294 | $259.65 |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 14 | $250.10 |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 12 | $248.34 |
| 80143 | <1% | 69 | $247.96 | |
| 86431 | <1% | 31 | $243.46 | |
| 82550 | <1% | 41 | $237.30 | |
| 82785 | <1% | 12 | $232.76 | |
| 83516 | <1% | 82 | $232.36 | |
| 86704 | <1% | 14 | $216.75 | |
| 86708 | <1% | 14 | $216.00 | |
| 86901 | <1% | 72 | $192.05 | |
| 36591 | <1% | 117 | $191.57 | |
| 86900 | <1% | 73 | $189.62 | |
| 80299 | <1% | 15 | $188.98 | |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 184 | $188.77 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 113 | $183.60 |
| 80179 | <1% | 54 | $174.36 | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,675 | $173.53 |
| 51702 | <1% | 12 | $145.80 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 2,712 | $121.94 |
| 82977 | <1% | 12 | $114.68 | |
| 84480 | <1% | 12 | $108.40 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,736 | $107.62 |
| 73080 | <1% | 13 | $103.76 | |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 197 | $92.17 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 147 | $88.09 |
| 97161 | <1% | 24 | $73.15 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 906 | $63.63 |
| 84520 | <1% | 13 | $61.76 | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 14 | $59.50 |
| 88304 | <1% | 24 | $52.07 | |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | <1% | 17 | $50.76 |
| A4216 | Sterile water, saline and/or dextrose, diluent/flush, 10 ml | <1% | 413 | $35.32 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 76 | $33.96 |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 164 | $17.13 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 290 | $16.10 |
| J2550 | Injection, promethazine hcl, up to 50 mg | <1% | 14 | $13.68 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 894 | $13.55 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 48 | $10.33 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 118 | $6.10 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 924 | $5.65 |
| J7643 | Glycopyrrolate, inhalation solution, compounded product, administered through dme, unit dose form, per milligram | 0% | 72 | $0.00 |
| J2710 | Injection, neostigmine methylsulfate, up to 0.5 mg | 0% | 18 | $0.00 |
| 3048F | 0% | 333 | $0.00 | |
| 3044F | 0% | 108 | $0.00 | |
| 3049F | 0% | 328 | $0.00 | |
| J0330 | Injection, succinylcholine chloride, up to 20 mg | 0% | 26 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialRUSH, ANDREW (PRESIDENT)
| Provider | Location | Paid |
|---|---|---|
| Somerset Health Services INC | Somerset, PA | $160K |
| Somerset Health Services, INC. | Johnstown, PA | $43K |
| Somerset Health Services, INC. | Somerset, PA | $14K |
| Somerset Health Services, INC. | Somerset, PA | $13K |
| UPMC Somerset | Somerset, PA | $7K |
| Somerset Health Services INC | Somerset, PA | $6K |
| Somerset Health Services, INC. | Somerset, PA | $4K |
| UPMC Somerset | Somerset, PA | $2K |
| UPMC Somerset | Somerset, PA | $1K |
| Somerset Health Services, INC. | Somerset, PA | $368.75 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.